Abstract Plasma cell-type Castleman disease (PCD) is often encountered when differentiating IgG4-related disease (IgG4-RD). Given that serum IgA is often elevated in Castleman disease, we investigated whether IgA expression levels in histological specimens can be used to differentiate between the two diseases. Lymph node lesions obtained from 12 IgG4-RD and 11 PCD patients were analysed by immunohistochemistry with anti-IgG, -IgG4, and -IgA antibodies. In addition to all 12 cases of IgG4-RD, 8/11 cases (72.7 %) of PCD also met the diagnostic criteria of IgG4-RD (serum IgG4 C135 mg/dl and IgG4/ IgG-positive cells C40 %). IgA-positive cells were sparsely and densely distributed in IgG4-RD and PCD cases, respectively. The median number of IgA-positive cells ± SD in all 12 cases of IgG4-RD was 31 ± 37 cells per three high-powered fields (3HPFs) (range 4-118 cells/ 3HPFs). In contrast, the median number of IgA-positive cells, which was significantly higher in all 11 cases of PCD, was 303 ± 238 cells/3HPFs (range 74-737 cells/ 3HPFs) (P \ 0.001). In conclusion, our findings indicate that in cases where serum analysis-based data are unavailable, anti-IgA immunostaining can be used for differential diagnosis of IgG4-RD.
Introduction
IgG4-related disease (IgG4-RD) is a recently recognized systemic syndrome characterized by mass-forming lesions and an elevated level of serum IgG4 [1, 2] . The disease involves fibrosis and severe lymphoplasmacytic infiltration with abundant IgG4-positive cells in various organs such as pancreas, bile ducts, lacrimal and salivary glands, lungs, liver, kidney, prostate, retroperitoneum, arteries, and skin [2] . IgG4-RD also affects lymph nodes in middle-aged and elderly patients [3] [4] [5] . IgG4-related lymphadenopathy often lacks fibrosis and phlebitis, in contrast to other lesions affected in IgG4-RD [4, 5] , and there are five histological subtypes: multicentric Castleman-like (type I), reactive follicular hyperplasia-type (type II), interfollicular expansion and immunoblastosis (type III), progressively transformed germinal centers (PTGC)-type (type IV), and inflammatory pseudotumour-like (type V) [3, 5] . IgG4-positive cells usually infiltrate interfollicular areas in IgG4-related lymphadenopathy [4, 5] . In the PTGC type, IgG4-positive cells are mainly observed in germinal centers, and lymphoplasmacytic infiltration is also observed in interfollicular areas with numerous eosinophils [5] . Since IgG4-related lymphadenopathy responds well to steroid therapy, it should be differentiated from malignant lymphoma, other lymphoproliferative disorders, and interleukin (IL)-6 syndromes such as Castleman disease and rheumatoid arthritis (RA) [6] [7] [8] . IL-6 syndrome is often encountered when diagnosing IgG4-related lymphadenopathy, since it frequently presents with lesions infiltrated by large numbers of IgG4-positive plasma cells and elevated serum IgG4 levels [7, 8] .
Castleman disease is a rare idiopathic atypical lymphoproliferative disorder classified according to histopathological findings of affected lymph nodes; the two major histological variants are the hyaline-vascular and plasma cell types [9] . Plasma cell-type Castleman disease (PCD) is characterized by lymphoplasmacytic infiltration with small and regressive germinal centers [7] . These histological findings can lead to confusion in diagnosing IgG4-related lymphadenopathy, especially type I [5, 7] . PCD patients frequently have systemic manifestations such as fever, night sweats, and weight loss (so-called multicentric Castleman disease), accompanied by abnormal laboratory findings of anaemia, hypoalbuminaemia, an elevated level of C-reactive protein (CRP), and hypergammaglobulinaemia [10] . Although the serum IgA level is significantly higher in PCD than in IgG4-RD patients [7] , a comparative histological analysis of IgA expression in PCD and IgG4-RD has not been previously reported.
In this study, we investigated the diagnostic value of IgA expression in differentiating IgG4-related lymphadenopathy from PCD.
Materials and methods

Patients
Tissue samples included lymph node lesions from 12 IgG4-RD and 11 PCD patients. All cases were retrieved from the surgical pathology consultation files of the Department of Pathology, Okayama University, Japan. The study protocol was approved by the Institutional Review Board of Okayama University, Okayama, Japan.
Preliminary diagnostic criteria for IgG4-RD included an elevated serum IgG4 level (C135 mg/dl) and infiltration of IgG4-positive cells into affected lymph nodes (IgG4/IgGpositive cell ratio, C40 %) [2] . IgG4-RD patients included nine males and three females aged 36-73 years (mean = 64.5 years) (Table 1) , with multiple and localized lymph node swelling observed in three and nine patients, respectively. Nine cervical, one mediastinal, one supraclavicular, and one inguinal lymph node biopsy specimens were examined. Histological subtypes of these IgG4-related lymphadenopathy samples included three cases of multicentric Castleman disease-like, two cases of reactive follicular hyperplasia-type, and seven cases of PTGC-type. Extranodal lesions were also detected in three patients.
PCD cases with fully available laboratory data comprised the control group (Table 2) . These cases were diagnosed in combination with clinical symptoms, abnormal laboratory data, and characteristic histological findings. PCD patients included eight males and three females aged 35-67 years (mean = 54.0 years). Of the 11 patients, 10 showed systemic lymph node swelling and one showed a localized swollen lateral cervical lymph node. Five inguinal, three cervical, one axillary, one intraabdominal, and one supraclavicular lymph node biopsy specimen were examined.
Histological examination and immunohistochemistry
Surgically biopsied lymph node specimens were fixed in 10 % formaldehyde and embedded in paraffin. Serial 4 lm-thick sections were cut from paraffin-embedded tissue blocks and stained with hematoxylin and eosin (HE). Sections were stained using an automated Bond Max instrument (Leica Biosystems, Wetzlar, Germany) with the following primary antibodies: polyclonal IgG 
Statistical analysis
Data are presented as median value ± standard deviation (SD). Statistical analyses included the Mann-Whitney U test and receiver operating characteristic (ROC) curves were carried out using SPSS software v.21.0 (SPSS Inc., Chicago, IL, USA). A P value \0.05 was considered statistically significant.
Results
Laboratory findings
Laboratory data are summarized in Table 2 . IgG4-RD patients showed anaemia (3/12), hypoalbuminaemia (2/11), and slightly elevated CRP level (2/11), but none had high platelet counts (0/12). In contrast, all 11 PCD patients showed anaemia (P = 0.002) and elevated serum CRP level (P \ 0.001) as well as hypoalbuminaemia (9/10; P \ 0.005) and high platelet count (6/11; P \ 0.001).
Serum IL-6 level was elevated (median = 14.5 pg/ml) in cases of PCD with available data, whereas serum IL-6 data was available for only one IgG4-RD patient (2.3 pg/ml). Serum IgM level was not elevated in IgG4-RD and PCD patients (P = 0.545), except in two and one cases, respectively.
Serum IgG and IgG4 levels
The median serum IgG value in IgG4-RD cases was 2078 ± 1856 mg/dl (range 1149-6715 mg/dl) (Fig. 1) ; five cases had an IgG level within the reference range (870-1700 mg/dl), while seven showed elevated serum IgG concentration. In contrast, the median serum IgG value was higher in PCD cases at 5254 ± 1498 mg/dl (range 2955-7148 mg/dl) (P = 0.004).
The median serum IgG4 value in IgG4-RD and PCD cases was 596 ± 689 mg/dl (range 141-2070 mg/dl) and 465 ± 478 mg/dl (range 150-1500 mg/dl), respectively, with no difference observed between the two groups (P = 0.740). However, median serum IgG4/IgG ratio was lower for PCD than for IgG4-RD (8.9 ± 6.9 %, range 5.1-26.8 vs. 23.2 ± 14.4 %, range 9.1-56.8 %, respectively; P = 0.001).
Serum IgA level
None of the eight cases of IgG4-RD with available data showed elevated serum IgA levels (C410 mg/dl); the median value was 157 ± 81 mg/dl (range 85-325 mg/dl) (Fig. 1) . In contrast, the median serum IgA value in PCD cases was higher at 621 ± 192 mg/dl (range 299-807 mg/ dl) (P \ 0.001) and was elevated in eight of 11 cases. Differences between the two groups were evaluated with the MannWhitney U test (*P \ 0.05). All IgG4-RD and PCD cases showed elevated serum IgG4 level (135 mg/dl). However, serum IgG4/IgG ratio was lower in PCD than in IgG4-RD cases. On the other hand, serum IgA level was higher in PCD than in IgG4-RD cases
IgG and IgG4 expression in histological specimens
Numerous plasma cells were observed in IgG4-RD and PCD lymph node specimens, most of which were positive for IgG (Fig. 2) . In IgG4-RD and PCD cases, the median number of IgG-positive cells was 926 ± 315 cells/3HPFs (range 539-1472 cells/3HPFs) and 1735 ± 361 cells/ 3HPFs (range 1269-2591 cells/3HPFs), respectively (P \ 0.001) (Fig. 3) . Most IgG-positive cells in IgG4-RD specimens expressed IgG4 (Fig. 2) ; the median number was 589 ± 295 cells/3HPFs (range 404-1242 cells/ 3HPFs) (Fig. 3) . The median IgG4 ?/IgG ? cell ratio in IgG4-RD was 71.4 ± 13.4 % (range 52.0-94.9 %) (Fig. 3) , which met the histological diagnostic criteria for IgG4-RD (IgG4/IgG-positive cells C40 %). In contrast, PCD cases showed a variable number of infiltrating IgG4-positive cells (P = 0.235) (Fig. 2) ; the median number was 756 ± 481 cells/3HPFs (range 210-1689 cells/3HPFs) (Fig. 3) . The median IgG4 ?/IgG ? cell ratio in PCD was 53.4 ± 19.4 % (range 13.0-78.4 %) (Fig. 3) . Although the ratio was lower in PCD than in IgG4-RD (P = 0.001), eight out of 11 PCD cases (72.7 %) met the histological criteria for IgG4-RD.
Immunohistochemical analysis of IgA expression
Few IgA-positive cells were observed in IgG4-RD cases, whereas numerous positive cells were detected in PCD specimens, mainly in interfollicular areas (Fig. 2) . The median number of IgA-positive cells in IgG4-RD and PCD cases was 31 ± 37 cells/3HPFs (range 4-118 cells/3HPFs) and 303 ± 238 cells/3HPFs (range 74-737 cells/3HPFs), respectively (Fig. 3) . Hence, the number of IgA-positive cells was greater in PCD than in IgG4-RD (P \ 0.001).
An ROC curve for differential diagnosis of PCD from IgG4-RD was generated based on the number of IgApositive cells/3HPFs (Fig. 4) . The curve had a cut-off value of 97 cells/3HPFs, as determined by the Youden index (sensitivity ? specificity -1) [11] ; this value had 90.9 % sensitivity and 91.7 % specificity. The area under the curve (AUC) was 0.966.
Discussion
In this study, abnormal laboratory findings including anaemia, hypoalbuminaemia, elevated platelet count, and elevated CRP and IL-6 values were observed along with [7] . In addition, 72.7 % of PCD patients fulfilled the diagnostic criteria for IgG4-RD (serum IgG4 C135 mg/dl and IgG4/IgG-positive cells C40 %). Thus, an increase in the number of IgG4-positive cells-which characterizes IgG4-RD [2-5]-is not sufficient for differentiating IgG4-RD from PCD, which requires a comprehensive diagnostic procedure that includes serological as well as histological findings and information on clinical course [5] .
PCD patients often show increased serum IgG4 levels, as reported in this study [7] . However, we found that the serum IgG4/IgG ratio in PCD cases was around 10 %, which was statistically lower than that observed in IgG4-RD cases. This can help to distinguish IgG4-RD from PCD in combination with other serological markers such as haemoglobin, platelet, albumin, CRP, and IL-6 levels.
Although it is difficult to distinguish IgG4-related lymphadenopathy from PCD based solely on HE staining results [7] , IgA immunolabelling revealed a statistically robust difference that can potentially be used for differentiating between the two diseases. The AUC (0.966) was close to 1, indicating that IgA-positive cell counts have good overall diagnostic performance [11] . The cut-off value obtained from the ROC analysis (97 cells/3HPFs) suggests that a differential diagnosis based on immunohistochemistry is possible even when sufficient serological data are lacking. IgA immunohistochemistry is, therefore, recommended when there is insufficient serological data, and cases with [100 IgA-positive cells/3HPFs should not be diagnosed as IgG4-RD. These criteria may be applied to situations where IgG4-RD and PCD must be distinguished in organs other than lymph nodes, because both diseases can affect other organs such as the kidney [12] and lungs [13] .
The mechanism underlying the development of IgG4-RD has been extensively investigated since the disease was first recognized in 2001 [14] . However, it is not known why the serum level of IgG4 among all immunoglobulin classes is elevated, and why IgG4-positive cells infiltrate lesions in IgG4-RD [14] . Recent evidence has implicated increased IL-4 and -10 levels in the production of IgG4 in IgG4-RD [15] . In contrast, Castleman disease is caused by an elevation in serum IL-6 level [16] . IL-6 induces the maturation of activated B cells into plasma cells, leading to polyclonal immunoglobulin production [16] . This results in an increase in serum level of not only IgG (including IgG4), but also of other classes of immunoglobulin such as IgA, which may be reflected by the abundance of IgA-positive cells in lymph nodes of PCD specimens. Increased serum IL-6 concentration is also associated with other serological abnormalities such as elevated serum CRP and platelet count, since IL-6 is a major stimulatory factor for hepatocytes and multipotent hematopoietic progenitors [16] .
Lymph node lesions with plasmacytosis that are present in hyper-IL-6 syndromes other than Castleman diseasesuch as RA-were not examined in this study. Clinical symptoms and laboratory findings, including the presence of specific autoimmune antibodies, are required to distinguish IgG4-RD from these hyper-IL-6 syndromes [8] . Inflammatory lesions other than those observed in hyper-IL-6 syndrome have also been reported, such as inflammatory granulation tissue and epulis, in which plasma cell infiltration is observed [17] . Since plasmacytic infiltration is an integral part of IgG4-RD diagnosis, it must be interpreted in an appropriate clinical and histopathological context.
Conclusion
The diagnosis of IgG4-RD requires a combination of clinical information, pathological findings, and test results that include serum IgA values. The IgA immunohistochemistry findings obtained in this study can be used to improve current diagnostic criteria for IgG4-related lymphadenopathy.
